Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
15 Apr 2016 ELCC 2016 Press Release: Studies Confirm Benefit of Plasma Genotyping to Predict Treatment Benefit in Patients with Non-Small-Cell Lung Cancer Lung and other thoracic tumours
15 Apr 2016 ELCC 2016 Press Release: Patients with EGFR Expressing Non-Small-Cell Lung Cancer Benefit Most from Necitumumab Added to Chemotherapy Lung and other thoracic tumours - Anticancer agents & Biologic therapy
14 Apr 2016 ELCC 2016 News: Possibility of Overtreatment Linked to Clinically-Diagnosed Early-Stage Lung Cancer Lung and other thoracic tumours
14 Apr 2016 ELCC 2016 News: Elderly Patients with Malignant Pleural Mesothelioma Should Not Be Excluded from Extended Pleurectomy Decortication Lung and other thoracic tumours
14 Apr 2016 ELCC 2016 Press Release: Immunotherapy With Live Bacterium Improves Response Rate in Malignant Pleural Mesothelioma Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
14 Apr 2016 ELCC 2016 Press Release: Osimertinib Given as First-line Treatment May Alter Biology of EGFR-Mutated Non-Small-Cell Lung Cancer Lung and other thoracic tumours - Anticancer agents & Biologic therapy
25 Mar 2016 Combined Inhibition of DDR1 and Notch Signalling for KRAS-Driven Lung Adenocarcinoma Translational research - Lung and other thoracic tumours
14 Mar 2016 FDA Expands Use of Crizotinib in Advanced NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
29 Feb 2016 EMA Recommends Extending Indications for Afatinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
26 Feb 2016 EMA Recommends Extending the Use of Nivolumab Genitourinary cancers - Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
21 Dec 2015 European Medicines Agency Recommends Two New Indications for Ramucirumab Lung and other thoracic tumours - Gastrointestinal cancers - Anticancer agents & Biologic therapy
21 Dec 2015 European Medicines Agency Recommends Granting a Conditional Marketing Authorisation for Osimertinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
21 Dec 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Necitumumab Lung and other thoracic tumours - Anticancer agents & Biologic therapy
21 Dec 2015 European Medicines Agency Recommends to Extend Therapeutic Indications for Erlotinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
19 Dec 2015 ESMO Asia 2015 News: Durvalumab, Tremelimumab Duo Promising in Advanced NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy